Dr. David Edward Marcinko is past Editor-in-Chief of the prestigious “Journal of Health Care Finance” who was named “Health Economist of the Year” in 2010. He is a Federal and State court approved expert witness featured in hundreds of peer reviewed medical, business, management, physician-focused financial planning and economic trade publications [AMA, ADA, AOA, APMA, AAOS, ANA, ACA, Physicians Practice, Investment Advisor, Physician’s Money Digest, JAFAS and MD News, etc].

And, as a former licensed Registered Investment Advisor [RIA], and former Certified Financial Planner®, Dr. Marcinko helped managed various private hedge funds and endowment funds for hospitals and other organizations:

Previously, served as CEO for the Institute of Medical Business Advisors [iMBA, Inc], a public health, economics, finance; policy, management and education administration consulting firm with offices in five [5] states.  All companies were start-ups or founding matrix units which launched and grew into market responsive corporations. Applied for US patents; and received trade and register marks, and numerous copyrights. I understand financial statements, and the positives / negatives of debt and leverage.

In fact, as a managerial healthcare accountant, I’ve held budgetary responsibility [fixed, variable and hybrid; cost plus [+] and cost minus [-] and zero-based] to $50-M, with P&L stewardship accountability to $150 million dollars, satisfying investors and stakeholders alike.

Professional Securities, Financial Certifications and Licenses 

Formerly Included: Series #7 (general securities), Series #63 (uniform securities state law), and Series #65 (investment advisory) licenses from the National Association of Securities Dealers (FINRA-NASD), and the Securities Exchange Commission [SEC] with a life, health, disability, variable annuity, and property-casualty license from the State of Georgia.

Research Grants

The Research Project Grant (R01) is the original and historically oldest grant mechanism used by NIH. The R01 provides support for health-related research and development based on the mission of the NIH. R01s can be investigator-initiated or can be solicited via a Request for Applications. The R03 grant mechanism will support small research projects that can be carried out in a short period of time with limited resources. The NIH has standardized the Small Grant (R03) application characteristics, requirements, preparation, and review procedures in order to accommodate investigator-initiated (unsolicited) applications.

Demonstrated track record in or potential for securing external grant awards from such agencies as the National Institutes of Health, Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention, Patient-Centered Outcomes Research Institute (PCORI), Health Resources & Services Administration (HRSA), National Science Foundation, and other funding agencies

ACADEMIC FUNDS ACQUIRED [$10-million plus; career aggregate-to-date]

  • Intra-Mural Funding: $1,525,000.00 aggregate [Financial Services firms]
  • Extra-Mural Funding: $2,750,000.00 aggregate [Pharmaceutical companies]
  • Private Funding: $6,250,000.00 aggregate [Hedge funds]

Corporate Grant and Funding Success:

  • Public Funding: $150,000,000.00 aggregate [Wall Street]

Understanding of Federal regulations and agency guidelines for the conduct and management of sponsored research, including NSF, DHHS, NIH, USDA, US Dept. of Education, DOD, NEA, and NEH. Knowledge of OMB Uniform Guidance 2 CFR 200, Cost Principles, and Audit Requirements for Federal Awards. Knowledge of and experience with, NSF FastLane/, ERA Commons/ASSIST, and other electronic proposal submission and reporting mechanisms.

Pending / past grant applications are to the NIHCM, Thomas Jefferson University, Hearst Population Health Prize, Duke University Center for Advanced Hindsight Start-Ups and the NIH.



© Content copyrighted 2000-2023 to present. All rights reserved, USA.